Traws Pharma appoints KPMG as new independent auditor, replacing Ernst & Young

Traws Pharma, Inc.

On July 16, 2024, Traws Pharma's Audit Committee engaged KPMG as its new independent registered public accounting firm for the year ending December 31, 2024.
During the fiscal years 2022 and 2023 and interim period through July 16, 2024, the company did not consult KPMG on accounting principles or any disagreements/reportable events.
Ernst & Young provided a letter to the SEC dated July 19, 2024, agreeing with the company's statements regarding the auditor change.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.